Details for New Drug Application (NDA): 010093
✉ Email this page to a colleague
NDA 010093 describes BIPHETAMINE 7.5, which is a drug marketed by Ucb Inc and is included in one NDA. Additional details are available on the BIPHETAMINE 7.5 profile page.
The generic ingredient in BIPHETAMINE 7.5 is amphetamine resin complex; dextroamphetamine resin complex. There are fifty-five drug master file entries for this compound. Additional details are available on the amphetamine resin complex; dextroamphetamine resin complex profile page.
The generic ingredient in BIPHETAMINE 7.5 is amphetamine resin complex; dextroamphetamine resin complex. There are fifty-five drug master file entries for this compound. Additional details are available on the amphetamine resin complex; dextroamphetamine resin complex profile page.
Summary for 010093
| Tradename: | BIPHETAMINE 7.5 |
| Applicant: | Ucb Inc |
| Ingredient: | amphetamine resin complex; dextroamphetamine resin complex |
| Patents: | 0 |
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 10MG BASE;EQ 10MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 6.25MG BASE;EQ 6.25MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 009
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 3.75MG BASE;EQ 3.75MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
